<DOC>
	<DOCNO>NCT01845883</DOCNO>
	<brief_summary>In proposal investigator three Specific Aims use human patient population model system ; 1 ) identify role Basal Ganglia ( BG ) perceptual decision making ; 2 ) determine whether Basal Ganglia contribute decision make condition visual uncertainty ; 3 ) determine whether cerebellum play role perceptual decision-making condition visual uncertainty . The investigator design experiment use healthy human human disease know affect Basal Ganglia cerebellum , Parkinson 's Disease , dystonia non-dystonic cerebellar damage . With approach investigator test follow hypothesis : 1 ) Patients Parkinson 's Disease dystonia difficulty healthy control make perceptual decision face sensory uncertainty ; sensory information certain , patient show improved decision-making still impaired relative healthy human . Hypothesis 2 : If ambiguous sensory information aid prior information , patient Parkinson 's Disease dystonia unable use prior ( bias/memory ) information inform decision . Hypothesis 3 : Deep Brain Stimulation ( DBS ) Basal Ganglia structure improve ability patient use prior information inform decision face sensory uncertainty . Hypothesis 4 : Both cholinergic dopaminergic medical therapy improve ability patient use prior information inform decision . Hypothesis 5 : Patients non-dystonic cerebellar damage similar healthy control performance perceptual decision make task condition visual uncertainty . The overarch framework application mechanism ( D1 striatal synaptic plasticity ) operate reward learning play role learn use stimulus prior perceptual decision-making task face uncertainty . Because Parkinson 's Disease dystonia share deficits striatal circuitry , patient deficit task similar . Because non-dystonic cerebellar patient dysfunction striatal circuit , show deficit ability use stimulus prior guide choice uncertain condition . In event patient show deficit , provide evidence unexplored role cerebellum perceptual decision-making .</brief_summary>
	<brief_title>Perceptual Decision Making Under Conditions Visual Uncertainty</brief_title>
	<detailed_description>In study , investigator aim determine whether patient Parkinson 's disease ( PD ) alter perceptual decision-making . The result experiment shed important light enigmatic symptom see patient disorder movement . In study subject perform computer generate visual task involve report direction arrow less difficult see computer screen . Eye movement monitor use video eye tracker . The system completely non-invasive position front , subject 's line sight avoid interfering ability perform task . Subjects report decision either eye movement direction perception arrow direction . Trials proceed follow : central point appear screen . Subjects ask look fixation point . After random delay time , patch spot appear place center fixation spot , embed patch arrow . The contrast arrow patch vary high value low . At high contrast direction arrow point clear low contrast unclear . The task subject make rapid eye movement soon decide direction arrow point . A sound played indicate correct choice . On trial sensory information ambiguous subject tell 'make best guess ' target arrow point . Unknown subject investigator manipulate probability one target correct one . This latter manipulation test whether subject use probability information inform decision . The investigator particularly interested whether probability information use preferentially sensory information ambiguous . The total number subject enrol study approximately 120 . Subject group follow : Healthy human age 30 80 PD ( age 45 80 ) , dystonia ( age 30-80 ) cerebellar lesion ( age 30-80 ) include undergone DBS surgery treat PD dystonia . The total duration session approximately 2 hour . Each patient group include DBS perform two session task - one medication one medication , hence total duration study 4 hour group ( 2 different session different day ) . These patient group free session time routine physician visit time work best .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<criteria>Group 1 Age Sex match healthy control : Age 1880 Years Group 2 Patients Parkinson 's Disease No DBS : `` med '' `` med '' ( test separate session ) total 2 session Age 4580 Years Unified PD rating scale ( UPDRS ) Mini mental health Status ( MMHS ) Group 3 Patients Parkinson 's Disease already consent DBS ( STN ) : Age 4580 Years Unified PD rating scale ( UPDRS ) Mini mental health Status ( MMHS ) Group 4 Patients Parkinson 's Disease already consent DBS ( GPi ) : Age 4580 Years Unified PD rating scale ( UPDRS ) Mini mental health Status ( MMHS ) Group 5 Patients Cervical Dystonia No DBS Age 3080 year FahnMarsden dystonia rating scale ( FMDRS ) Mini mental health Status ( MMHS ) Group 6 Patients Generalized Dystonia ( Ach ) No DBS : Age 3080 year FahnMarsden dystonia rating scale ( FMDRS ) Mini mental health Status ( MMHS ) Group 7 Patients Dystonia already consent DBS ( GPi ) : Age 3080 year FahnMarsden dystonia rating scale ( FMDRS ) Mini mental health Status ( MMHS ) Group 8 Patients Cerebellar Stroke Age 3080 Years Routine neuro exam Mini mental health Status ( MMHS ) Group 9 Patients Cerebellar Ataxia Age 3080 Years Routine neuro exam Mini mental health Status ( MMHS ) Visual impairment ocular motility disorder Inability sit 30 minute task plus 2030 minute instruction time , setup , wait time . For Group 1 ( Age Sex Matched Controls ) , additional exclusion criterion neurological disease drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>